Deutsche Märkte öffnen in 2 Stunden 29 Minuten

Sorrento Therapeutics, Inc. (SRNE)

NasdaqCM - NasdaqCM Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
4,5600+0,2300 (+5,31%)
Börsenschluss: 04:00PM EST
4,5500 -0,01 (-0,22%)
Nachbörse: 07:59PM EST
Melden Sie sich an, um eine Nachricht zu posten.
  • s
    stephen
    $SRNE conversation
    if Bristol Myers wants to avoid downstream damages when PSS losses lawsuit to SRNE , its in their best interest to buy SRNE or partner with SRNE to avoid forever royalties damages IMHO

    the reason Aldoxorubicin was delayed, and the reason
    $SRNE
    's Cynviloq [ superior generic paclitaxel version of abraxane - in Catch n Kill lawsuit now waiting decision arbitration from 3 Judge "panel"] - this
    $CELG

    $BMY
    Non Compete Agreement stymied Aldoxorubicin's FDA Guidance with 505(b)(2) - they FDA - actually gave
    $CYTR
    the green light to file the NDA for Aldoxorubicin, but Kriegscam + Soon Shiong made a deal, that would delay Aldoxorubicin - but protect Abraxane because of patent expiration and the Non Compete - this put an extra 7 Billion dollars in
    $BMY
    's Celgene's pocket
  • A
    Ariadinvestor
    $AUPH conversation
    Only true longs like Singer/Kurt/sharon/LIT/Dan will be greatly rewarded. The later the buyout, the higher the BO price. There'll be no buyout until it's bought out. ⭐AUPH CEO says "good companies are not sold, they are bought ..."⭐ A great life-saving drug will sell itself well whether it is bought out or goes standalone. No bags, no gold! No patience, no fully filled gold bags!

    $AUPH $SRNE short squeeze is just a matter of time.

    James spammed:
    "
    Let me save you from future regret. My biggest regret is starting so late. From about 2012 I thought about buying some bitcoin, just putting like £10 in it but I either thought 'oh it's too late' or 'it's too complicated' and I did massively regret that.
    I've only been in crypto a few months, and I've already made more than I made in a year and a half of investing in stocks. It made me realize that you can never be too late when it comes to investing in crypto.
    Source for the right information, trading crypto might sound very complicated but it's something you can get the hang of with proper tutelage. I'd recommend a professional trader like Mrs Josephine Mariano for tips and predictions. She has a great review here on this little community. You can check below to reach out to her. It's always money making season, trade and start your journey to financial freedom today. It's never too late.
    "
  • A
    Ariadinvestor
    $AUPH conversation
    @john/Wayne/Dennis/GAN/Chevy 👈 I bother you? I would soon totally forget there's a disgusting sick thing named Chevy/Wayne/Dennis/GAN/john should you stop bothering me. How many times have I advised you to mute me? Your IQ is too low to appreciate my posts, which are not for you unless you learn to appreciate them from Pain, Lisa, Singer, K Smooth, cyaaa, Don Austin, joao, robin, H. Scott, et al. Link 2: https://finance.yahoo.com/quote/AUPH/community?messageId=9c8be420-5806-4e13-9b26-0df988a72fce&replyId=7ea3139b-7274-4897-9beb-79abc27a3b4e $AUPH / $SRNE short squeeze is just a matter of time.
  • M
    MikeD44
    $SRNE conversation
    $SRNE @Sal.. futhermore Sorrento Therapeutics is not a short term trade.. it's long term investment in an emerging bioscience research firm. Development of drug candidates happen over long time horizons not tied to the short term goals of impatient traders. If you were an either a well studied investor or successful trader you'd have recogized this basic fact going from the onset.. if you have anything at stake whatsoever (highly doubtful).

    Anyone who fails to understand the aforementioned is again a fool or misguided short seller putting funds at extreme risk for a short term gain likely never to occur or worse result in loss. Setting false expectations or blaming leadership for not executing within a period of time you set for your trade is setting yourself up to fail. Research proceeds on it's own time table not yours.

    Educate yourself.. grow up or leave.
  • A
    Anonymous
    $VXRT conversation
    So frustrating. Market starting to recover, and we remain in the dog house. Every day we get a small pop that shows promise, and then relentless selling.

    $SRNE and $INO came back from session lows, and we are dead in the water. I thought the presentation today would serve as some sort of catalyst, but nothing of note.
  • M
    MikeD44
    $SRNE conversation
    @Chuck $SRNE.. what we were discussing with respect to Scilex is the least of the spend as relates to the recent registration of the $5 bln mixed shelf. Sure you are keenly aware as astute investor focusing on emerging clinical stage bioscience firms.. the extreme challenges small firms face with not only cost of research but the expense of clinical trials.. not to mention FDA/NIH hurdles & roadblocks installed courtesy of big pharma. Going it alone without benefit of joint ventures or partnerships offer.. only intensifies pressure. From your experience what would you estimate cost of study for resiniferatoxin to treat severe pain associated with advanced cancer or the expense to initiate & continue paying for the study of Anti-CEA CAR-T + chemotherapy vs. chemotherapy alone in patients with CEA+pancreatic cancer & liver metastases.. what about the expense to study of the safety and efficacy of STI-6129 in patients with relapsed or refractory systemic AL Amyloidosis or study of intravenous COVI-MSC for treatment of COVID-19-induced acute respiratory distress. Don't need to run through the entire pipeline.. do I? Just one study for cancer takes years with costs rising into hundreds of millions to a billion dollars to bring to endpoint.

    Great number of these trials are ongoing.. some haven't commenced that need to while still others in preclinical need to be advanced seeking approval to begin.

    Mike Royal is doing a far better than respectable job of managing & prioritizing than his predecessor Dr. Jerome Zeldis now with BioSig.

    Not here in defense of Sorrento or to justify recent or past actions of leadership called into question.. just presenting facts as they are. Have there been fumbles.. sure there have. Will there be more.. of course there will. You know very well Sorrento is not the only bio playing it close to vest with shareholders not communicating as you think thought to. I can tell you with confidence there's more than adequate information in filings & white paper, reviews to satisfactorily answer most questions enabling one to "connect the dots". I feel completely at ease with what I'm able to gather & frankly thankful for less disclosure in some areas that would present significant risk to the company's IP if divulged.
  • M
    MikeD44
    $SRNE conversation
    @Chuck $SRNE you haven't noticed updates to CTs have improved measurably under Mike Royal's watch vs. Zeldis? Don't think we're seeing equal paces regards to decisions to move foward with studies.. to the contrary therein lies much progress. Royal.. alone certainly doesn't have the final word on funding trials, but his input is clearly visible. Trial status' are now updated to show completed (a first) further, proper decisions with regard to withdrawal as science advances with priority giving to most efficacious as demonstrated by STI-1499's migration to STI-2020/2099.

    Looks to me every attempt has/is being made to prepare for commercialization as far back as 2018 when the focus was to prepare for production of RTX. Sorrento was blindsided by Fortune Bio's rejection by the FDA of it's early test kits & has suffered slow paces since.. but we can see the issue of domestic manufacturing is being addressed (as you stated the final step to authorization). Truthfully.. in my opinion no one wants to go to market to generate revenues more than leadership. Hard to hold leadership to account calling for the removal of the CEO when in fact they are doing everything within their control to overcome disabling road blocks put up by big pharma & NIH/FDA. Lest you forget Henry Ji & team are responsible for development of this incredible pipeline / platform from the ground up & has resisted buyout attempts to continue the growth organically.. carefully & slowly assembling the resources to see it through. He has amassed a wealth of resources through aquisition & license deals unmatched by any other emerging bioscience firm of it's size in existence. He will see this through as demonstrated by his actions.. he's no quitter. Sorrento in my opinion will be come the dominant firm in Immunotherapy / Immuneoncology.. accomplishing what REGN & others could not.
  • A
    Ariadinvestor
    $SRNE conversation
    @Tim * I've never posted about exactly how many SRNE shares I own. Although I haven't added a single share since 11/18/2019 on which I added 10K shares at $1.545, I own far more than your 55K shares. I admit I took some profits at $10 & at $18.82 on 05/18/20 & on 08/10/20 "to take out cost basis & free roll it" in K Smooth's words. 😏 Why I don't post about exactly how many $SRNE / $AUPH shares I own? Once upon a time, ARIA dropped $0.50, & my enemy Yahoo Admin M/G/K.R/Sal cheered about my dropping $60,000 as he knew I owned 120K ARIA shares. 😁
  • R
    Russ
    $SRNE conversation
    Did you hear that sound? Only certain people can hear it. When you hear the sound your heart races. It’s the sound of an instant overnight stock jump when you least expect it. $SRNE could easily jump 100% at this share price. The right news will send this sound echoing in the ears of all shorts. The sound will then cause massive buying just so you have to cover. Do you hear that sound now? Because it’s coming. #2022 #SRNE2theMoon
  • A
    Anonymous
    $VXRT conversation
    While the past month has been brutal, we actually faired much better than most of our peers. $INO, $SRNE $VIR $NVAX etc etc. are all down way more - in some instances, close to 50%.

    As an example, our interday high on December 20th was 7.61. Based on todays close, we lost approximately 20%. $VIR on the other hand went from $58 to $33 (-43%), while $NVAX went from $236.5, all the way down to $112.5 (although it made up some of those losses today).

    $XBI as a whole is setting new lows daily. If misery loves company, Vaxart isn't doing all that bad compared to the sector.
  • R
    Russ
    $SRNE conversation
    I’m excited for $SRNE and everything that should be announced in January… should have a lot of news releases!!
  • A
    Ace
    $SRNE conversation
    The colossal missed opportunity for Covistix to get FDA approval cannot be underestimated. Ji should be removed ASAP! Many investors bought in because of promises about the $SRNE pipeline and still nothing. I'm very happy I voted NO on his raise!
  • A
    Ace
    $SRNE conversation
    When most of us bought in, this was a Covid play and we believed in Ji's confidence that he had Covi-Drops and Covi- Stix all ready to go. The pipeline was icing on the cake! As we close out the year, I've lost all confidence in Ji and realize he either purposely exaggerated the effectiveness of his products or is incompetent. Either way, longs are forced to hold just hoping to break even. I've lost confidence in Ji and $SRNE for keeping him.
  • M
    MikeD44
    $SRNE conversation
    Does Yahoo allow violations of it's TOS to continue after receiving multiple notifications? You bet they do..

    Sample of the violator's cooment history..

    MikeD44

    480 reactions

    Newest Reactions

    MikeD44

    9 hours ago
    Replied to a reaction

    $SRNE conversation

    @Hope is this even English? Do you understand civil discourse? Or is that lost on you?

    Reply

    MikeD44

    9 hours ago
    Replied to a reaction

    $SRNE conversation

    @Sal I’m a big dummy and I love Sorrento.

    Reply

    MikeD44

    9 hours ago
    Replied to a reaction

    $SRNE conversation

    Why would anyone leave a company that has no budget or oversight? Ji is too stupid to say “no”.

    Reply

    2

    Third violation sited..

    Don't lose your Yahoo Account - We reserve the right to remove any comment that doesn't comply with our Community Guidelines or Terms of Service, and to terminate a Yahoo Account for a violation.

    •Be courteous and stay on-topic.

    •Don’t incite violence or hatred towards others.

    •Don't make false statements, defame, or impersonate someone else.

    Are Yahoo board administrator(s) overseeing enforcement complicit allowing these violations to continue without accountability?

    Apparently so.
  • A
    Ariadinvestor
    $AUPH conversation
    @Pain 🙏 Thank you very much for helping me madden my haters! ⭐ Pain reposted: "Long live Ariadinvestor! Long live $SRNE !" 🙏 Thx! I have haters on both the $AUPH MB & the $SRNE MB. 😁 Maddening my haters is my online entertainment & hobby.😂

    What the share price will be when Dr. Ji achieves his goal of building Sorrento into a $200-$400 billion company? $671-$1,342! ⭐ Patience is the key to the ultimate success of a true long's investment. I don't sell but add more when it pulls back. I don't set stop loss. I don't buy on margin. What can the manipulators/shorts/paid-bashers do to my gold bags?
    ------------
    Sell now & come back after Dr. Ji achieves his goal? What the SP will be when Dr. Ji achieves his goal of building Sorrento into a $200-$400 billion company? $671-$1,342! ⭐ Patience is the key to the ultimate success of a true long's investment. I don't sell but add more when it pulls back. I don't set stop loss. I don't buy on margin. What can the manipulators/shorts/paid-bashers do to my gold bags?

    This is how I invest in biotech: 4. LAST BUT NOT LEAST, enjoy my hobby/online-entertainment of taunting/striking back provocateurs; 3. Take it easy at bad times; 2. Have patience; 1. Pick up the right gold bag stocks. I REALLY MEAN WHAT I'M SAYING. AUPH/SRNE's great science & pipeline will shine. Patience is the key to the ultimate success of the investors. Before Ariad was bought out, I had been accumulating its shares for 18.5 years with my belief that its great science & pipeline would shine. Time will let my haters know $SRNE / $AUPH are even big gold bags than $ARIA gold bags. Cheers!
    --------
    What the share price will be when Dr. Ji achieves his goal of building Sorrento into a $200-$400 billion company? $671-$1,342! ⭐ => $7.63 x 400B/2.275B = $1.342
  • A
    Ariadinvestor
    $SRNE conversation
    What characterizes a great small biotech stock is its price volatility. The winners are those who can stomach the volatility. I used to say only the ARIA true longs would be greatly rewarded. I was proven right. Now, I say only the faithful SRNE/AUPH true longs will be greatly rewarded. They will be the ultimate winners. Traders are gamblers playing the ZERO sum game. Singer: "Corby and Mark will be left behind." Yes, they have been left behind. Chief: "@Ariadinvestor You are not a real trader." Chief was right. I'm not a trader at all. I'm an investor accumulating the $SRNE / $AUPH gold bags.
  • A
    Ariadinvestor
    $AUPH conversation
    I am not responsible for causing mental disorders for anyone who hates my posts but hesitates to mute me, report me to Yahoo or choose to be driven off this message board. I tell truth about SRNE/AUPH by presenting facts & by joking about my enemy & the provocateurs. Taunting them is my online entertainment, which may affect certain people's mental states. The more you hate my posts, the more I post them. I accumulate $AUPH / $SRNE gold bags the way I accumulated ARIA gold bags. No bags no gold!
  • A
    Anonymous
    $VXRT conversation
    Man, Bio-tech getting smashed, completely erasing last weeks gains. So many stocks I'm tracking are registering 52 week lows.

    $OCGN got smashed to bits, losing 75% of its value in under 2 months. $SRNE, $INO and $IBIO also getting decimated.

    Hoping for a sector rotation to start the new year. Bio-tech is in the dog house right now.
  • T
    Todd
    $SRNE conversation
    The 1st Qtr of 2022 will be a blow out period for #SRNE.
  • S
    Stewart
    $SRNE conversation
    Sal is a liar and a fraud.

    This guy sound long to you or does he work for PSS in the basement of his mansion?

    Sal
    3 days ago
    Replied to a reaction
    $SRNE conversation

    @MikeD44 Keep trying! Maybe Finn can help?

    But I am in fact a long investor, and have never shorted this or any stock (did 3x short ETF in March of 2020 briefly)

    Sal
    4 hours ago

    @From OTC to NASDAQ There is no denying they have been slow and plodding...the share price reflects total disdain for Ji. Scilex is currently worth more than Sorrento if Semdexa gets approved...Ji not only ruined longs in 2021, he ruined his and Sorrento's reputation...

    Sal
    5 hours ago

    @Seeking Sigma Earnings will be released likely Friday night in a 10Q, Ji hiding from questions, and repeat 3 months later.

    Sal
    6 hours ago

    @Anthony Prepare for disappointment. Prepare to be ruined. This is Ji's maSal7 hours ago

    Sal
    7 hours ago

    @mark Who knows, but many a retail has been ruined! Their Covid pipeline has been a joke...retail bought it and funded Ji and teams nice lifestyle in sunny San Diego. Most of these retail holders are from terribletown middle America wishing and praying they deserve a better life. Ji ripped that from them coldly.

    Masterpiece. Enjoy it.

    Sal
    9 hours ago

    @Michael Watching retail beg at the 52 week low is priceless....they have been ruined.